vs

Side-by-side financial comparison of BuzzFeed, Inc. (BZFD) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $56.5M, roughly 1.0× BuzzFeed, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 0.6%). BuzzFeed, Inc. produced more free cash flow last quarter ($-12.0M vs $-167.0M).

BuzzFeed, Inc. is an American Internet media, news, and entertainment company with a focus on digital media. Based in New York City, BuzzFeed was founded in 2006 by Jonah Peretti and John S. Johnson III to focus on tracking viral content. Kenneth Lerer, co-founder and chairman of The Huffington Post, started as a co-founder and investor in BuzzFeed and is now the executive chairman.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

BZFD vs PHAT — Head-to-Head

Bigger by revenue
PHAT
PHAT
1.0× larger
PHAT
$57.6M
$56.5M
BZFD
Growing faster (revenue YoY)
PHAT
PHAT
+93.5% gap
PHAT
94.1%
0.6%
BZFD
More free cash flow
BZFD
BZFD
$155.0M more FCF
BZFD
$-12.0M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BZFD
BZFD
PHAT
PHAT
Revenue
$56.5M
$57.6M
Net Profit
$-26.8M
Gross Margin
86.7%
Operating Margin
-43.7%
Net Margin
-47.4%
Revenue YoY
0.6%
94.1%
Net Profit YoY
-186.4%
71.6%
EPS (diluted)
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZFD
BZFD
PHAT
PHAT
Q4 25
$56.5M
$57.6M
Q3 25
$46.3M
$49.5M
Q2 25
$46.4M
$39.5M
Q1 25
$36.0M
$28.5M
Q4 24
$56.2M
$29.7M
Q3 24
$55.6M
$16.4M
Q2 24
$41.1M
$7.3M
Q1 24
$37.0M
Net Profit
BZFD
BZFD
PHAT
PHAT
Q4 25
$-26.8M
Q3 25
$-7.4M
$-30.0M
Q2 25
$-10.8M
$-75.8M
Q1 25
$-12.7M
$-94.3M
Q4 24
$31.0M
Q3 24
$2.1M
$-85.6M
Q2 24
$-7.5M
$-91.4M
Q1 24
$-35.7M
Gross Margin
BZFD
BZFD
PHAT
PHAT
Q4 25
86.7%
Q3 25
87.5%
Q2 25
87.2%
Q1 25
86.9%
Q4 24
87.1%
Q3 24
85.6%
Q2 24
81.2%
Q1 24
Operating Margin
BZFD
BZFD
PHAT
PHAT
Q4 25
-43.7%
Q3 25
-12.9%
-30.8%
Q2 25
-7.5%
-151.7%
Q1 25
-38.1%
-276.5%
Q4 24
7.0%
Q3 24
2.8%
-433.0%
Q2 24
-13.6%
-1055.4%
Q1 24
-63.4%
Net Margin
BZFD
BZFD
PHAT
PHAT
Q4 25
-47.4%
Q3 25
-16.1%
-60.5%
Q2 25
-23.3%
-191.9%
Q1 25
-35.2%
-330.7%
Q4 24
55.2%
Q3 24
3.8%
-523.3%
Q2 24
-18.2%
-1248.6%
Q1 24
-96.5%
EPS (diluted)
BZFD
BZFD
PHAT
PHAT
Q4 25
$-0.72
Q3 25
$-0.20
$-0.41
Q2 25
$-0.28
$-1.05
Q1 25
$-0.33
$-1.31
Q4 24
$0.86
Q3 24
$0.05
$-1.32
Q2 24
$-0.20
$-1.56
Q1 24
$-0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZFD
BZFD
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$8.5M
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$49.4M
$-438.2M
Total Assets
$188.1M
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZFD
BZFD
PHAT
PHAT
Q4 25
$8.5M
$130.0M
Q3 25
$34.3M
$135.2M
Q2 25
$29.7M
$149.6M
Q1 25
$34.3M
$212.3M
Q4 24
$22.4M
$297.3M
Q3 24
$53.7M
$334.7M
Q2 24
$45.5M
$276.2M
Q1 24
$44.5M
Total Debt
BZFD
BZFD
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
BZFD
BZFD
PHAT
PHAT
Q4 25
$49.4M
$-438.2M
Q3 25
$75.9M
$-422.5M
Q2 25
$81.1M
$-405.8M
Q1 25
$93.8M
$-338.4M
Q4 24
$104.8M
$-253.6M
Q3 24
$71.7M
$-187.1M
Q2 24
$67.2M
$-233.8M
Q1 24
$73.7M
Total Assets
BZFD
BZFD
PHAT
PHAT
Q4 25
$188.1M
$259.1M
Q3 25
$211.2M
$240.3M
Q2 25
$210.4M
$250.2M
Q1 25
$203.2M
$294.2M
Q4 24
$221.4M
$378.3M
Q3 24
$276.5M
$387.0M
Q2 24
$272.9M
$319.4M
Q1 24
$299.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZFD
BZFD
PHAT
PHAT
Operating Cash FlowLast quarter
$-11.7M
$-166.8M
Free Cash FlowOCF − Capex
$-12.0M
$-167.0M
FCF MarginFCF / Revenue
-21.2%
-290.0%
Capex IntensityCapex / Revenue
0.5%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.7M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZFD
BZFD
PHAT
PHAT
Q4 25
$-11.7M
$-166.8M
Q3 25
$1.7M
$-14.1M
Q2 25
$-10.1M
$-62.7M
Q1 25
$1.3M
$-84.9M
Q4 24
$-4.6M
$-266.8M
Q3 24
$9.6M
$-63.6M
Q2 24
$-12.4M
$-70.7M
Q1 24
$-13.3M
Free Cash Flow
BZFD
BZFD
PHAT
PHAT
Q4 25
$-12.0M
$-167.0M
Q3 25
$892.0K
$-14.1M
Q2 25
$-10.5M
$-62.8M
Q1 25
$956.0K
$-84.9M
Q4 24
$-4.7M
$-266.9M
Q3 24
$9.3M
$-63.6M
Q2 24
$-12.5M
$-70.8M
Q1 24
$-13.4M
FCF Margin
BZFD
BZFD
PHAT
PHAT
Q4 25
-21.2%
-290.0%
Q3 25
1.9%
-28.6%
Q2 25
-22.7%
-159.0%
Q1 25
2.7%
-297.9%
Q4 24
-8.4%
-899.8%
Q3 24
16.7%
-389.0%
Q2 24
-30.5%
-966.2%
Q1 24
-36.2%
Capex Intensity
BZFD
BZFD
PHAT
PHAT
Q4 25
0.5%
0.4%
Q3 25
1.8%
0.1%
Q2 25
1.0%
0.2%
Q1 25
1.1%
0.1%
Q4 24
0.3%
0.5%
Q3 24
0.5%
0.3%
Q2 24
0.3%
0.6%
Q1 24
0.2%
Cash Conversion
BZFD
BZFD
PHAT
PHAT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.15×
Q3 24
4.59×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZFD
BZFD

Advertising$25.6M45%
Commerce And Other$16.3M29%
Content$14.7M26%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons